Ambica International Corporation is a leading pharmaceutical company based in the Philippines, with a total market share of 5.27% of the ethical prescription market. The company specializes in the importation, distribution, marketing, and selling of Branded Generics in the Ethical, OTC, and Nutraceutical segments within its territories, which includes the Philippines and Vietnam. Ambica’s aim is to provide every consumer access to safe, affordable, and effective medication, which has led to the company’s steady growth over the last 20 years. The company’s product portfolio covers at least 26 therapeutic segments and includes products from every therapeutic segment that covers a wide array of illnesses. Ambica’s core strength relies on its partners, both foreign and local. Its foreign partners consist of world-renowned manufacturers with state-of-the-art manufacturing facilities approved by highly regulated drug authorities, such as the USFDA, UKMHRA, TGA, EUGMP, and PICs member authorities. Whereas its local partners are known for their strong brand development in the market and have a strong supply chain reach within the Philippines and Vietnam. These factors have contributed to Ambica’s tremendous growth and development over the last 10 years. The company promotes its products through different divisions within the organization to target different market segments, with a strong focus on ethics, safety, and environmental awareness around their products, and patients’ health is always the first priority. Ambica specializes in the importation, distribution and marketing of a wide range of products within its territories of operation. Its product portfolio includes Patented Drugs, Branded Generic Drugs, Controlled Drugs, Cosmetics, Food Supplements, and Medical Devices. Additionally, the company provides extra services such as Molecular Diagnostics, FDA Registrations, FDA Facility Inspections, Product Quality Inspections, and Repackaging of Finished Formulations. As of 2022, the company had a total turnover of $150 million and represented manufacturers present in 50 different countries with over 3000 commercialized products in the nation’s leading drug stores and hospitals. Ambica’s management team, combined with the rest of their employees, work harmoniously and effectively in breaking bounds in the industry, making the company the 5th largest Pharmaceutical Company amongst Multinationals and the 2nd largest local Pharmaceutical Company in the Philippines. The company’s aim is to enrich the lives of every consumer by providing them with high-quality medication. With the company’s plans to expand within the ASEAN region over the next 5 years, Ambica’s core strength will continue to rely on its partners, both foreign and local, to maintain its unsurpassable growth and development. As one of the largest pharmaceutical company in the Philippines, Ambica International Corporation is dedicated to providing the best, safest, and most effective healthcare products to improve the well-being of every Filipino. We are committed to enhancing the affordability and availability of our products, making them accessible to everyone, regardless of their income or social status. In a rapidly evolving industry, our focus is on innovation, sustainability, and social responsibility. The Philippine pharmaceutical landscape is constantly changing, and we understand the importance of adapting to the evolving needs of our customers. As of 2022, the pharmaceutical market in the Philippines is valued at over $5 billion, with an annual growth rate of 5%. With our extensive product portfolio that includes over 3000 commercialized products, Ambica International Corporation holds a significant market share in the industry. MISSION Our mission is to be the trusted partner of every Filipino in their journey to achieve optimal health. We are dedicated to maintaining our high standards of quality, safety, and accessibility, ensuring that every product we provide is effective and reliable. As the industry leader, we will continue to innovate and expand our product portfolio to meet the changing needs of our customers. We will work tirelessly to support public health initiatives, partner with local healthcare providers, and continuously improve our products and services. At Ambica International Corporation, our goal is to be the driving force for health and wellness in the Philippines, enhancing the lives of every Filipino. VISION Our vision is to be the leading catalyst in enhancing the health and wellness of the nation while promoting economic development. We aim to be a driving force for health and wellness in the Philippines by providing high-quality, affordable healthcare products that are widely available throughout the country. We believe that access to healthcare should not be limited by geography, income, or social status. Therefore, we are committed to making a positive impact on the well-being of our customers by promoting health literacy and awareness in our communities. OUR VALUES As a pharmaceutical company in the Philippines, our ultimate goal is to empower the lives of our customers through accessible, available, affordable, and advocated medicines. Let me elaborate on these four values in the context of our company. Our focus on accessibility, availability, affordability, and advocacy reflects our commitment to empowering the lives of our customers. We are driven by our mission to provide high-quality healthcare products and services that are accessible and affordable to everyone, and we will continue to advocate for the health and well-being of the communities we serve.